Prevention and Management of Patients with Diabetes at University of Hertfordshire

HomeHealth & Fitness

Prevention and Management of Patients with Diabetes at University of Hertfordshire

my-portfolio

[ad_1] About the project Diabetes is the fastest growing health threat of our times with 4.5 million diagnosed in the UK and expected

Associate Professor in Genetic Epidemiology & Public Health/Honorary Public Health Consultant at University of Leicester
Lecturer in Translational Science (Education and Research) at University of Sussex
Lecturer Practitioner – Osteopathic Medicine at Plymouth Marjon University

[ad_1]

About the project

Diabetes is the fastest growing health threat of our times with 4.5 million diagnosed in the UK and expected to exceed five million by 2025. Treatment of diabetes patients is a financial burden on the NHS given the chronic nature of the disease and its cost, which is equivalent to 10% of the NHS budget in England and Wales. The treatment of diabetes is complicated and resource intensive, requires a multidisciplinary diabetes team, and is subject to treatment variations in line with the disease stages. In addition, diabetes patients are generally referred to specific diabetes clinics depending on the complications associated with the disease. The current diabetes care delivery model is unsustainable given the severe resources constraints, the huge backlog of patients waiting for treatment post Covid19, and the forecasted future increase in patients. Therefore, there is a dual need to reduce the incidence of diabetes and redesign the patients’ management and treatment pathways so that the disease burden on the NHS is reduced and care is delivered in a timely manner and to the required quality standards. Two areas require further exploration: (i) what is the impact of interventions to reduce diabetes incidence and future demand; (ii) which pathways reconfigurations have the highest potential to improve the delivery performance of diabetes services (DSs). The research methodology will be mainly quantitative combining simulation modelling and forecasting methods. The study will take place in one of the NHS Integrated Care Systems (ICSs) in England. Information and data will be gathered from a mixture of primary and secondary sources, including Department of Health, NHS, and the ICS. The research outcomes are expected to provide evidence regarding the best interventions and policies to reduce diabetes burden and improve DSs performance and provide the evidence to inform the policy making process in the NHS. Travel and fieldwork costs will be covered, as will conference attendance and staff development activities for the appointee.

Applicant requirements

Applicants should have at least an upper second-class honours degree in a relevant discipline. A master degree in a relevant field will be advantageous.

The studentship is open to UK/EU and international applicants.

How to apply

Applicants are required to provide the following documents:

  • A completed application form, available for download at: http://www.herts.ac.uk/__data/assets/pdf_file/0010/31105/uh-application-form.pdf.;
  • A 2000 words research proposal;
  • Two academic references;
  • Copies of qualification certificates and transcripts;
  • Certification of English language competence (minimum IELTS 6.5 or equivalent) for candidates for whom English is not their first language;
  • A copy of passport photo page.

Please send completed applications to the Doctoral College at doctoralcollegeadmissions@herts.ac.uk, using the following format in the email subject line: “Business School_studentship application_Lebcir”.

For enquiries concerning this studentship and the Business School please contact Professor Reda Lebcir (m.r.lebcir@herts.ac.uk).   

Key dates

Closing date for applications: 11 August 2023.

Interview dates: late August to early September 2023.  

Studentship start date: by mutual negotiation.

[ad_2]

Source link

COMMENTS

WORDPRESS: 0
DISQUS: